We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enzyme Responsible for the Benefits of Caloric Restriction Identified

By LabMedica International staff writers
Posted on 14 Oct 2009
Researchers are beginning to define the molecular basis for the improvement in health and increase in life expectancy induced by reducing caloric intake and maintaining a reduced calorie diet.

Investigators at University College London (United Kingdom) genetically engineered a line of "knockdown" mice that lacked the gene for the enzyme ribosomal S6 Kinase 1 (S6K1). More...
S6K1 is a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, which guides the organism's response to changing levels of nutrients.

Results comparing normal and S6K1 knockdown mice were published in the October 2, 2009, issue of the journal Science. They showed that at an age of 600 days (the mouse equivalent of middle age) female knockout mice were leaner, and had stronger bones than did the normal females. The female knockdown mice did not show the usual age-related decline in insulin sensitivity. They performed better at motor performance tasks and were more inquisitive and exploratory. On average, the female knockout mice lived for 950 days, over 160 days longer than the control group. While the male knockout mice demonstrated the same overall better health characteristics, they did not experience the extended lifespan.

"Blocking the action of the S6K1 protein helps prevent a number of age-related conditions in female mice," explained senior author Dr. Dominic Withers, professor of diabetes and endocrinology research at University College London. "The mice lived longer and were leaner, more active and generally healthier than the control group. We added "life to their years" as well as "years to their lives"."

Related Links:
University College London



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.